Source: The Scotsman Online
Newly incorporated MIME Technologies Ltd, based in the Centre for Health Science, Inverness is rapidly progressing towards making its' innovative first aid support technology available for wide spread use by Spring 2016.
The British Red Cross trialled their system at the BT Murrayfield Stadium on the opening weekend of the 2016 Six Nations Championship, the Scotland v England Calcutta Cup clash.
MIME, which stands for “Managing Information in Medical Emergencies” is technology specifically designed to support the first aider as the first person on scene. The system consists of proprietary intelligent software running on mobile devices that link with next generation, non‐invasive wireless medical sensors. The result is a lightweight wireless tool that enables the safe assessment and monitoring of a patient’s vital signs during a medical emergency.
The company is a spin out from the University of Aberdeen, with the technology originally developed through extensive research with specialist clinical input led by Professor Philip Wilson. Before a full market launch, MIME Technologies decided to undertake this study to further explore MIME's usability and usefulness in a real life situation.
The new CEO for MIME Technologies, Dr Alasdair Mort, a digital health specialist, commented “Thanks to the British Red Cross we’ve had a tremendously valuable opportunity to trial MIME in the field. MIME has been developed through collaboration with the Scottish Ambulance Service and the Digital Health & Care Institute specifically to address the problems that first aiders face and I’m delighted by the positive response we’ve received from the first aiders using MIME at Saturday’s Scotland v England match.”
Nick Barr, Head of Event First Aid and Ambulance Operations for British Red Cross said: “British Red Cross looks to incorporate new advances in technology wherever this can support our services. We have a wealth of experience in first aid provision and development, and were delighted to work with MIME Technologies to trial this new innovation in the field.”